spacer
 
|

Retina Practicum:

Focusing on Optimal Management

A Case-Based Educational Symposium Archive

Jointly presented by the University of Nebraska Medical Center and ASiM.

Supported by an educational grant from Regeneron Pharmaceuticals, Inc.

OVERVIEW
The management of retinal diseases is transforming at an extraordinary rate. Such change is driven by large-scale research efforts, an increasing number of clinical trials, a large number of therapeutic candidates in the clinical development pipeline, and the availability of newer therapeutic strategies, like anti-VEGF agents. While these therapies have revolutionized the approach to treatment for patients with retinal diseases, including age-related macular edema, diabetic macular edema, and retinal vein occlusion, many questions remain with regard to the selection of optimal therapies, frequency of injections, duration of treatment, and the best monitoring schedules. This interactive web-based enduring activity will provide retina specialists and comprehensive ophthalmologists with cutting-edge, forefront clinical information in an interactive, case-based format, which will serve as a forum for discussion to help them determine how best to apply data from clinical trials into daily practice.

GOAL
The goal of this activity is to provide retina specialists and comprehensive ophthalmologists with the most current clinical knowledge and therapeutic strategies for the optimal treatment and management of patients with retinal diseases.

TARGET AUDIENCE
This activity is designed for retina specialists and comprehensive ophthalmologists. No prerequisites required.

LEARNING OBJECTIVES
After completing this activity, the participant should be better able to:
  • EVALUATE the latest clinical data for the treatment of retinal diseases.
  • COMPARE the effect of dosing strategies on the efficacy and safety of current and emerging therapies for the management of retinal vascular diseases.
  • APPLY results from the latest clinical trials to clinical case scenarios and real-life situations.

PARTICIPATING FACULTY
Quan Dong Nguyen, MD, MSc (Co-Chair)
McGaw Professor and Chairman
University of Nebraska
Medical Center Department of Ophthalmology and Visual Sciences
Omaha, NE

Diana V. Do, MD (Co-Chair)
Vice Chair for Education
Associate Professor of Ophthalmology
Director of Residency Training Program
Director of the Carl Camras Center for Innovative Clinical Research in Ophthalmology
Stanley M. Truhlsen Eye Institute
University of Nebraska Medical Center
Omaha, Nebraska

Jeffrey S. Heier, MD
Director, Vitreoretinal Service
Ophthalmic Consultants of Boston
Co-Director of the Vitreoretinal Fellowship
OCB/Tufts Medical School
Boston, Massachusetts

Peter K. Kaiser, MD
Chaney Family Endowed Chair in Ophthalmology Research
Professor of Ophthalmology
Cleveland Clinic Lerner College of Medicine
Cole Eye Institute
Cleveland, Ohio

ACCREDITATION
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Nebraska Medical Center, Center for Continuing Education designates this Internet Enduring Material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

JOINT PROVIDERSHIP STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Nebraska Medical Center and ASiM. The University of Nebraska Medical Center is accredited by the ACCME to provide continuing medical education for physicians.

DISCLAIMER
The University of Nebraska Medical Center, Center for Continuing Education, presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The University of Nebraska Medical Center, Center for Continuing Education assumes no liability for the information herein.

DISCLOSURE
It is the policy of The University of Nebraska Medical Center to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, and staff involved in the development of this activity have disclosed any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The intent of this disclosure is not to prevent a faculty or staff member with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The University of Nebraska Medical Center has identified and resolved any and all faculty conflicts of interest prior to the release of this activity.

FACULTY AND STAFF DISCLOSURES
Quan Dong Nguyen, MD, MSc: Consultant/advisor for Bausch & Lomb, Inc, Genentech, Inc, Regeneron Pharmaceuticals, Inc, and Santen Pharmaceutical Co, Ltd; recipient of grant/research funding from Genentech, Inc, Pfizer Inc, and Regeneron Pharmaceuticals, Inc.

Diana V. Do, MD: Consultant/advisor for Bausch & Lomb and Santen Pharmaceutical Co, Ltd; and a recipient of grant/research funding from Genentech, Inc, and Regeneron Pharmaceuticals, Inc.

Jeffrey S. Heier, MD: Advisor/consultant and a recipient of grants/research support from Acucela Inc, Aerpio, Alcon, Inc, Genentech, Inc, Genzyme Corporation, Notal Vision, Ohr Pharmaceutical Inc, and Regeneron Pharmaceuticals, Inc; advisor/consultant for Allegro, Allergan, Inc, Bayer AG, Forsight Vision, Kala Pharmaceuticals Inc, Neurotech, Oraya Therapeutics, sanofi-aventis, LLC, Stealth Peptides, and Xcovery; and a recipient of grants/research support from Alimera Sciences, Lpath Incorporated, Novartis AG, Ophthotech Corporation, and QLT Inc.

Peter K. Kaiser, MD: Advisor/consultant for Alcon, Inc, ArcticDx, Bayer AG, Kanghong, Novartis AG, Ophthotech Corporation, Oraya Therapeutics, and Regeneron Pharmaceuticals, Inc; and a stock/shareholder for SKS Ocular.

The planners or other members at The University of Nebraska Medical enter, Center for Continuing Medical Education, who control content have no relevant financial relationships to disclose.

OFF-LABEL PRODUCT DISCUSSION
The following faculty members have disclosed that their presentation will reference unlabeled/unapproved use of drugs or products:

Dr Nguyen–Bevacizumab.
Dr Do–Bevacizumab.
Dr Heier–Preclinical data and ongoing clinical trials on the following agents may be discussed: aflibercept, bevacizumab, AKB9779, dexamethasone implant, multivitamin with lutein, and/or triamcinolone. Dr Kaiser–Bevacizumab in patients with retinal diseases.

The estimated time to complete this activity: 90 minutes

Release date: October 22, 2014. Expiration date: October 22, 2015.

PRIVACY POLICY
For the University of Nebraska Medical Center privacy policy, please click here.

SYSTEM REQUIREMENTS
Pentium 800 processor or greater, Windows 98/NT/200/XP or Mac OS 9/X or later, Microsoft Internet Explorer, Safari, Firefox, Windows Media Player 9.0 or later Flash player, 128 MB of RAM Monitor settings: High color at 800 x 600 pixels, sound card and speakers, Adobe Acrobat Reader.

ACTIVITY
Instructions: Please complete the pre-assessment for the web archive, listen to and watch the presentations, and complete the post-assessment and evaluation to receive CME credit. A certificate of participation will be available online immediately following successful completion of the activity.

AGENDA
Pre-Assessment

Overview and Goals

Interactive Case Discussions
  • Patients with Age-Related Macular Degeneration
  • Patients with Diabetic Macular Edema
  • Patients with Retinal Vein Occlusion
Question & Answer Session/Conclusions

Post-Assessment

Submit a case to review at event:


procced to pretest


spacer  
  spacer
Advanced Studies in Medicine © 2014 Contact Us
spacer  
spacer